Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (3053)	5/30/1998 11:53:00 PM
From: Solid	Read Replies (2) \| Respond to of 9523

icos (won't justify with caps!) I put so little credence to it I didn't realize others are quoting IT as the reason Pfizer was held back! I guess all you need are fancy names -Bill Gates deep pocket and 13% stake -former Amgen folks- a 'potential' product -small capitalization, what 800 mil vs. PFE of 100 billion+, to imply huge upward room to grow (no pun intended), lots of speculators to hype you and here you go instant Christmas! From CNNFN- But ICOS (ICOS) rallied 5-11/16, or 35 percent, to 21-15/16, following a news report that the company is developing an impotence drug that could be better than Pfizer's (PFE) blockbuster pill Viagra. According to the report in the latest issue of BusinessWeek magazine, ICOS' pill, currently being tested in clinical trials, could have fewer side effects than Viagra. [ Pfizer ] 's stock dropped 1-1/16 to 105-9/16. ICOS was the most actively traded Nasdaq stock. Friday night I did see an interview with some fund manager or analyst and he was sure icos was going to 35 this yr. and much higher, for above reasons-too bad-talk about riding someones coat tails!